Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Shukla

Showing results (101-110 of 229) with videos related to

Pageof 23
Sort By:
Antiviral Research|July 25, 2021
Prophylactic treatment with BX795 blocks activation of AKT and its downstream targets to protect vaginal keratinocytes and vaginal epithelium from HSV-2 infectionKrishnaraju Madavaraju, Tejabhiram Yadavalli, Sudhanshu Kumar Singh, et al.
Journal of Virology|November 28, 2014
Characterization of a proteolytically stable D-peptide that suppresses herpes simplex virus 1 infection: implications for the development of entry-based antiviral therapyDinesh Jaishankar, Abraam M Yakoub, Anita Bogdanov, et al.
Iscience|December 20, 2022
Topical phenylbutyrate antagonizes NF-κB signaling and resolves corneal inflammationRaghuram Koganti, Tejabhiram Yadavalli, Yogesh Sutar, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 22, 2022
Safety, efficacy and delivery of multiple nucleoside analogs via drug encapsulated carbon (DECON) based sustained drug release platformTejabhiram Yadavalli, Joshua Ames, David Wu, et al.
The Biochemical Journal|August 12, 2004
Characterization of heparan sulphate 3-O-sulphotransferase isoform 6 and its role in assisting the entry of herpes simplex virus type 1Ding Xu, Vaibhav Tiwari, Guoqing Xia, et al.
Phytotherapy Research : PTR|December 31, 2009
In vitro antiviral activity of neem (Azardirachta indica L.) bark extract against herpes simplex virus type-1 infectionVaibhav Tiwari, Nissar A Darmani, Beatrice Y J T Yue, et al.
Viruses|September 28, 2021
Protease, Growth Factor, and Heparanase-Mediated Syndecan-1 Shedding Leads to Enhanced HSV-1 EgressGhadah A Karasneh, Divya Kapoor, Navya Bellamkonda, et al.
Trends in Microbiology|January 16, 2021
Dysregulation of Cell Signaling by SARS-CoV-2Rahul K Suryawanshi, Raghuram Koganti, Alex Agelidis, et al.
Experimental Eye Research|February 8, 2021
Pathobiology and treatment of viral keratitisRaghuram Koganti, Tejabhiram Yadavalli, Raza Ali Naqvi, et al.
Virology|December 17, 2009
Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entryChristopher D O'Donnell, Maria Kovacs, Jihan Akhtar, et al.
Pageof 23

Showing results (101-110 of 229) with videos related to

Sort By:
Pageof 23
Antiviral Research|July 25, 2021
Prophylactic treatment with BX795 blocks activation of AKT and its downstream targets to protect vaginal keratinocytes and vaginal epithelium from HSV-2 infectionKrishnaraju Madavaraju, Tejabhiram Yadavalli, Sudhanshu Kumar Singh, et al.
Journal of Virology|November 28, 2014
Characterization of a proteolytically stable D-peptide that suppresses herpes simplex virus 1 infection: implications for the development of entry-based antiviral therapyDinesh Jaishankar, Abraam M Yakoub, Anita Bogdanov, et al.
Iscience|December 20, 2022
Topical phenylbutyrate antagonizes NF-κB signaling and resolves corneal inflammationRaghuram Koganti, Tejabhiram Yadavalli, Yogesh Sutar, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 22, 2022
Safety, efficacy and delivery of multiple nucleoside analogs via drug encapsulated carbon (DECON) based sustained drug release platformTejabhiram Yadavalli, Joshua Ames, David Wu, et al.
The Biochemical Journal|August 12, 2004
Characterization of heparan sulphate 3-O-sulphotransferase isoform 6 and its role in assisting the entry of herpes simplex virus type 1Ding Xu, Vaibhav Tiwari, Guoqing Xia, et al.
Phytotherapy Research : PTR|December 31, 2009
In vitro antiviral activity of neem (Azardirachta indica L.) bark extract against herpes simplex virus type-1 infectionVaibhav Tiwari, Nissar A Darmani, Beatrice Y J T Yue, et al.
Viruses|September 28, 2021
Protease, Growth Factor, and Heparanase-Mediated Syndecan-1 Shedding Leads to Enhanced HSV-1 EgressGhadah A Karasneh, Divya Kapoor, Navya Bellamkonda, et al.
Trends in Microbiology|January 16, 2021
Dysregulation of Cell Signaling by SARS-CoV-2Rahul K Suryawanshi, Raghuram Koganti, Alex Agelidis, et al.
Experimental Eye Research|February 8, 2021
Pathobiology and treatment of viral keratitisRaghuram Koganti, Tejabhiram Yadavalli, Raza Ali Naqvi, et al.
Virology|December 17, 2009
Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entryChristopher D O'Donnell, Maria Kovacs, Jihan Akhtar, et al.
Pageof 23